Brett H. Yamane

发表

Hepatocellular carcinoma: current management.

M Wasif Saif, M. Saif, S. Weber, 2010, Current problems in surgery.

Differential internalization of hu14.18‐IL2 immunocytokine by NK and tumor cell: impact on conjugation, cytotoxicity, and targeting

M. Patankar, S. Gillies, R. Reisfeld, 2011, Journal of leukocyte biology.

Body Mass Index does not Affect Postoperative Morbidity and Oncologic Outcomes of Total Mesorectal Excision for Rectal Adenocarcinoma

G. Kennedy, N. Ballian, E. Foley, 2010, Annals of Surgical Oncology.

Long-term follow-up after meshectomy with acellular human dermis repair for postherniorrhaphy inguinodynia.

Brett H. Yamane, J. Starling, M. Koopmann, 2011, Archives of surgery.

Dose-Dependent Toxicity of a Commercially Available Demineralized Bone Matrix Material

H. Vinters, Jeffrey C. Wang, L. Kanim, 2001, Spine.

The development of antibody-IL-2 based immunotherapy with hu14.18-IL2 (EMD-273063) in melanoma and neuroblastoma

M. Albertini, Brett H. Yamane, J. Hank, 2009, Expert Opinion on Investigational Drugs.

Radiofrequency Ablation Combined with KS-IL2 Immunocytokine (EMD 273066) Results in an Enhanced Antitumor Effect against Murine Colon Adenocarcinoma

D. Mahvi, S. Gillies, Brett H. Yamane, 2009, Clinical Cancer Research.

Liver-directed treatment modalities for primary and secondary hepatic tumors.

S. Weber, Brett H. Yamane, 2009, The Surgical clinics of North America.

Blunt thoracic aortic injury: open or stent graft repair?

C. Acher, J. Hoch, G. Tefera, 2008, Surgery.

The development of antibody-IL-2 based immunotherapy with hu14.18-IL2 (EMD-273063) in melanoma and neuroblastoma

M. Albertini, Brett H. Yamane, J. Hank, 2009, Expert opinion on investigational drugs.

Liver-directed treatment modalities for primary and secondary hepatic tumors.

S. Weber, Brett H. Yamane, 2009, The Surgical clinics of North America.